CoreValve Initiates European Trial Using Its ReValving System

CoreValve announced that its proprietary percutaneous ReValving system, which features a pericardium aortic heart valve mounted in a self-expanding frame, has been implanted successfully for the first time in Europe in the cardiac catheterization laboratory at the Heart Center, Siegburg, Germany. As a result, the 73-year-old female patient was able to avoid open-heart surgery to treat her aortic calcified stenosis.

Business Wire (http://home.businesswire.com/portal/site/home/index.jsp?epi-content=GENERIC&newsId=20050222005665&ndmHsc=v2*A1106485200000*B1109118072000*DgroupByDate*J2*L1*N1000003*Zcorevalve&newsLang=en&beanID=2133606841&viewID=news_view)